Zacks Investment Research lowered shares of Addus Homecare (NASDAQ:ADUS) from a strong-buy rating to a hold rating in a research note released on Tuesday.
According to Zacks, “ADDUS HOMECARE is a comprehensive provider of a broad range of social and medical services in the home. The company’s services include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care. Its consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its payor clients include federal, state and local governmental agencies, the Veterans Health Administration, commercial insurers and private individuals. Addus operates its business through two divisions, home & community services and home health services. The home & community services are social, or non-medical, in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living whereas the home health services are medical in nature and include physical, occupational and speech therapy, as well as skilled nursing. “
Other equities research analysts have also recently issued research reports about the company. BidaskClub upgraded Addus Homecare from a hold rating to a buy rating in a report on Thursday, October 11th. Oppenheimer raised their target price on Addus Homecare from $72.00 to $80.00 and gave the company an outperform rating in a research note on Wednesday, November 7th. Royal Bank of Canada initiated coverage on Addus Homecare in a research note on Monday, October 8th. They issued an outperform rating and a $81.00 target price for the company. Finally, Robert W. Baird upgraded Addus Homecare from a neutral rating to an outperform rating and raised their target price for the company from $72.00 to $75.00 in a research note on Monday. Two equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Addus Homecare presently has a consensus rating of Buy and a consensus target price of $76.63.
ADUS traded up $0.05 on Tuesday, hitting $65.19. 1,600 shares of the company were exchanged, compared to its average volume of 148,987. The company has a debt-to-equity ratio of 0.37, a current ratio of 4.19 and a quick ratio of 4.19. Addus Homecare has a 12 month low of $33.25 and a 12 month high of $77.82. The firm has a market cap of $846.02 million, a price-to-earnings ratio of 44.88, a PEG ratio of 1.88 and a beta of -0.12.
Addus Homecare (NASDAQ:ADUS) last posted its quarterly earnings results on Tuesday, November 6th. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.08. Addus Homecare had a return on equity of 9.55% and a net margin of 3.25%. The business had revenue of $137.63 million for the quarter, compared to analyst estimates of $139.43 million. As a group, sell-side analysts anticipate that Addus Homecare will post 1.67 EPS for the current year.
In other Addus Homecare news, CEO R Dirk Allison sold 1,080 shares of Addus Homecare stock in a transaction on Tuesday, January 22nd. The stock was sold at an average price of $63.00, for a total transaction of $68,040.00. Following the completion of the transaction, the chief executive officer now owns 40,995 shares in the company, valued at $2,582,685. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider W Bradley Bickham sold 705 shares of Addus Homecare stock in a transaction on Thursday, January 17th. The shares were sold at an average price of $64.13, for a total value of $45,211.65. Following the transaction, the insider now owns 21,010 shares of the company’s stock, valued at approximately $1,347,371.30. The disclosure for this sale can be found here. Insiders have sold 925,185 shares of company stock valued at $67,049,102 in the last quarter. 34.80% of the stock is owned by company insiders.
Large investors have recently made changes to their positions in the business. State Board of Administration of Florida Retirement System increased its holdings in shares of Addus Homecare by 5.8% in the 4th quarter. State Board of Administration of Florida Retirement System now owns 3,316 shares of the company’s stock worth $225,000 after purchasing an additional 182 shares in the last quarter. Legal & General Group Plc increased its holdings in shares of Addus Homecare by 32.5% in the 3rd quarter. Legal & General Group Plc now owns 1,428 shares of the company’s stock worth $100,000 after purchasing an additional 350 shares in the last quarter. Cambridge Investment Research Advisors Inc. increased its holdings in shares of Addus Homecare by 3.2% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 12,414 shares of the company’s stock worth $843,000 after purchasing an additional 381 shares in the last quarter. Smith Asset Management Group LP increased its holdings in shares of Addus Homecare by 3.6% in the 3rd quarter. Smith Asset Management Group LP now owns 26,034 shares of the company’s stock worth $1,826,000 after purchasing an additional 900 shares in the last quarter. Finally, LS Investment Advisors LLC bought a new stake in shares of Addus Homecare in the 4th quarter worth $66,000. Institutional investors and hedge funds own 92.87% of the company’s stock.
About Addus Homecare
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.
Featured Article: Bull Market
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.